Tag: Pharmaceutical

Crescita
Global

Crescita to Acquire Strategic Assets of Occy Laboratory

LAVAL, Quebec – Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has agreed to acquire all of the non-real estate business assets of Occy Laboratory Inc., (“Occy”), a Laval-based manufacturer and distributor of high-quality dermocosmetic products (the “Transaction”). “This tuck-in acquisition aligns with our long-term vision to become a leading Canadian … Continue reading Crescita to Acquire Strategic Assets of Occy Laboratory

Impact Newswire
Stevanato Group
Europe

Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro

PIOMBINO DESE, Italy – Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that its Board of Directors has appointed Franco Stevanato, a current director and the Executive Chairman of the Company, as its new Chief Executive Officer. Mr. Stevanato is succeeding as Chief Executive Officer Franco … Continue reading Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro

Impact Newswire
Harrow
United States

Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial

NASHVILLE, Tenn.–(BUSINESS WIRE)–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, is pleased to announce the appointment of Greg DiPasquale as Senior Vice President, Head of Commercial, effective immediately. DiPasquale will oversee sales, marketing, and sales operations for Harrow’s rapidly growing portfolio of branded ophthalmic products. This new role reflects Harrow’s commitment to enhancing its leadership structure to support the Company’s continued growth. John Saharek, … Continue reading Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial

Impact Newswire
Pfizer
United States

Pfizer Announces New Chief Strategy and Innovation Officer

NEW YORK – Pfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be a member of Pfizer’s Executive Leadership Team reporting to Chairman and Chief Executive Officer, Dr. Albert Bourla. He joins Pfizer from Citi, where he served as Head of Global Healthcare, Managing Director Equity Research. Prior … Continue reading Pfizer Announces New Chief Strategy and Innovation Officer

Impact Newswire
Alentis
Europe

Alentis Appoints Alberto Toso Chief Scientific Officer

BASEL, Switzerland – Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing treatments for organ fibrosis and Claudin-1 positive tumors, announced today that Dr. Alberto Toso has been appointed as Chief Scientific Officer effective immediately. Alberto joined Alentis in 2021 as Head of Oncology. “It is becoming increasingly clear that #Claudin-1 has tremendous potential for treating cancer. As CSO, it is my objective to harness the … Continue reading Alentis Appoints Alberto Toso Chief Scientific Officer

Impact Newswire
Kindeva Drug Delivery
United States

Denis Johnson Joins Kindeva Drug Delivery as Chief Operating Officer to Lead Global Operations

WOODBURY, Minn. & ST. LOUIS–(BUSINESS WIRE)–Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced that Denis Johnson has joined the company as its new Chief Operating Officer (COO). Denis joins Kindeva to lead global operations for all Kindeva’s state-of-the-art manufacturing, research, and development facilities located across the U.S. and U.K. Joining @KindevaDD as its new Chief Operating Officer is industry expert Denis Johnson to lead … Continue reading Denis Johnson Joins Kindeva Drug Delivery as Chief Operating Officer to Lead Global Operations

Impact Newswire
Nuvation Bio
United States

Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer

Ms. Sjogren brings nearly 30 years of biopharmaceutical experience building commercial organizations and leading successful oncology launches Pending acquisition of AnHeart Therapeutics and expanded leadership strongly positions Nuvation Bio to potentially become a commercial organization by the end of 2025 March 28, 2024 08:00 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs … Continue reading Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer

Impact Newswire
Pyramid Labs
Global, United States

Pyramid Labs Appoints Dirk Lange as CEO and Announces a Doubling of Commercial Fill-Finish Capacity

COSTA MESA, Calif.–(BUSINESS WIRE)–Pyramid Labs, Inc. (“Pyramid” or the “Company”), a leader in drug product contract development and manufacturing with expertise in proteins, oligos, and peptides, announced today the appointment of Dirk Lange as Chief Executive Officer. Medhat Gorgy, who founded Pyramid in 1988 and has led the Company’s growth and evolution over its 36-year history, will continue to support the business as the Company’s … Continue reading Pyramid Labs Appoints Dirk Lange as CEO and Announces a Doubling of Commercial Fill-Finish Capacity

Impact Newswire